The Fc receptors (FcR), which belong to the immunoglobulin (Ig) superfamily, bind to specific Ig isotypes with varying affinities triggering complex immune defense responses. Several of the Fctk that lack signaling motifs in their cytoplasmic domains rely on associated subunits to transmit signals. Two classes of Fctk that bind the Fc portion oflgG, FcyRI, and FcytklIIa associate with a subunit shared among several FcR, the y chain, which is involved in receptor expression and signal transduction. In this report, we propose that a novel role for y chain is to enhance the affinity of Fcytk for ligand. Our findings demonstrate that FcytkI requires y-chain association to attain high affinity binding for monomeric IgG, and suggest that the intermediate binding affinity of the FcyIklIIa isoform results from its association with y chain. The affinity increase conferred by y chain appears to be mediated through the transmembrane domain of the Fcytk, with no requirement for the cytoplasmic domain of the receptor.
T
he Fc receptors (Fctk) 1, which bind the Fc region of Ig, provide an important link between cellular and humoral branches of the immune system by triggering several immune responses including phagocytosis, endocytosis, antibody-dependent cytotoxicity, release of inflammatory mediators, and enhancement of antigen presentation upon immune complex-mediated clustering (1, 2) . Three classes of receptors for IgG (Fcytk) have been identified--FcyRI, FcytklI, and Fcyl~.-III--and all but one are integral membrane proteins constituted ofglycosylated extracellular Ig-like domains, a short transrnembrane domain, and a cytoplasmic domain. FcytklIIb is not a transmembrane receptor, since it is anchored to the membrane by a glycosyl phosphatidylinositol (GPI) link. FcyRI is distinguished from the other Fcytk members in having a unique third extracellular domain, while FcytklI and FcyP, III are two extracellular domain receptors. Fc',/RI and FcyRIIIa both associate with y chain, a 20-kD disulfide-linked, homodimeric, signal-generating subunit that also associates with the high affinity IgE FcR (FceRI) and the IgA FcR (FcottL) (3) (4) (5) . In addition to functioning as a signal-transducing subunit, y chain also plays a role in the cell-surface expression of some of these receptors; for example, FceR.I and the FcylLIIIa isoform require association with y chain for expression in COS cells (6, 7) . Expression of FcylLI and FcodL in eukaryotic cells, however, is independent of y-chain cotransfection (8, 9 (10) . Although the high affinity binding of FcytkI for monomeric IgG (K a = 108-9 M -1) (11, 12) has been attributed to the presence of the third extracellular domain (8, 13, 14) , FcylLI transfected into COS cells binds ligand with an affinity that is fivefold lower (K~ = 5.0 • 107 M -1) than that measured on cells that naturally express the receptor (8, 14) . These results suggest that some factor(s), present in the cells that naturally express FcyRI and absent in COS cells, participates in the high affinity binding. Among these factors, one potential candidate is the y-chain subunit. In the present study, we demonstrate that the affinity of both human and murine FcyRl increases when y chain is cotransfected with these receptors, and that the affinity increase correlates with association with y chain and is independent of the cytoplasmic domain of FcytkI. We also observed that the intermediate affinity of FcyRIIIa appears to be dependent upon y-chain association.
Materials and Methods
Cells and Cell Culture. U937, a human monocyte cell line from American Type Culture Collection (Rockville, MD), and N10F7, a mouse 3T3 fibroblast cell line stably transfected with human Fc~/RI eDNA, were maintained in RPMI 1640 (Life Technologies, Gaithersburg, MD) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT), 2 mM t-glutamine, 100 U/ml penicillin, and 100 Ixg/ml streptomycin. COS-7 cells were cultured in DMEM with the supplements listed above. The N10F7 medium also contained 0.5 mg/ml G418 (Life Technologies). U937 cells were cultured with 100 U/ml human rlFNy (Genentech, San Francisco, CA) 48 h before each experiment to increase FcyRI expression.
Plasmid Constructs and Transfections. The human FcyRI cDNA cloned into the pCDM vector was described by Ernst et al. (3) . The human y-chain cDNA in vector pSVL was a kind gift from Dr. Jean-Pierre Kinet (National Institute of Allergy and Infectious Diseases, Bethesda, MD). FcyRIIIb, FcyRIIIa, FcyRIIIa GPI, and murine y-chain cDNAs were all generous gifts from Dr. Jeffrey V. Ravetch (Memorial Sloan-Kettering Cancer Center, New York). FcyRIIIa and FcyRIIIb cDNA were further subcloned in the vector pcDNA1 (Invitrogen, San Diego, CA). The murine FcyRI cDNA was a kind gift from Dr. Duane W. Sears (University of California, Santa Barbara, CA), the human macrophage mannose receptor cDNA in the vector pHMR was from Dr. Benjamin A. Kruskal (Children's Hospital, Boston, MA), and the pRSVCAT vector was from Dr. Lai-Chu Wu (The Ohio State University, Columbus, OH). A truncated human FcyRI, designated FF, was constructed by PCR amplification using FcyRl cDNA as a template, and truncation was confirmed by sequencing. The FcyRI sense primer, containing a stop codon at the predicted amino acid residue 319, was 5'-GAC AAT ACG TAA AGA ACT GAA ATG AAA GAA-3', and the antisense primer was 5'-ACT GAG CCG CTG CTA CGT GG-3'. The cDNAs were transiently transfected into COS-7 cells by the diethylaminoethyl-dextran method described previously (3), using 1-2 btg/ml DNA, and the cells were analyzed 48 h after transfection.
Ligand-binding Assays and Scatchard Analysis. Approximately 5 X
10 s COS-7 cell transfectants or N10F7 cells per well were cultured in 24-well plates overnight to confluence. Cells were incubated in triplicate for 2-4 h on ice with 0.15 ml of increasing concentrations (0.5-10 or 30 Izg/ml) of monomeric 12sI-IgG2a labeled with an efficiency of 95% by the chloroglycouril method. After the cells were washed to remove unbound 12sI-IgG, they were solubilized in 0.5 ml 3 N NaOH, and radioactivity was measured with a gamma scintillometer. For cells in suspension, unbound ~2Sl-IgG was removed by centrifuging the cell suspension through oil (bis(2-ethylhexyl)phthalate/dibutylphthalate 1:1.1), as previously described (11) . The nonspecific binding was determined by the amount of radioactivity binding to wells containing mock-transfected COS-7 and untransfected 3T3, or by incubating the COS-7, N10F7 transfectants, and U937 with radioligand in the presence of 100-fold excess unlabeled IgG2a. Both methods of determining nonspecific binding resulted in background counts that represented 0.1-0.3% of the input of radioactivity. Binding data were analyzed using the Collection of Radioligand Binding Analysis Programs (Elsevier-BIOSOFT, Cambridge, UK). Results were expressed as the mean -SEM of 3-13 experiments, and statistical analysis was performed using Student's t test.
Immunoadsorption and Western Analysis. (mlgG2a) was obtained from Me&rex (Annandale, NJ). The rabbit anti-y-chain serum was a generous gift from Dr. Jean-Pierre Kinet (National Institute of Allergy and Infectious Diseases), as was the mAb anti-y-chain 4D8 from Dr. Jarema Kochan (Hoffman-La Roche, Nutley, NJ). COS-7 transfectants were lysed for 1-2 h on ice in 1% digitonin (Calbiochem, San Diego, CA), 20 mM triethanolamine, pH 7.8, 150 raN1 NaC1, 0.12% Triton X-100, and 2 mM PMSF (Sigma Immunochemicals, St. Louis, MO), and clarified supernatants were incubated with mAbs bound to Sepharose 4B (Phannacia Fine Chemicals, Piscataway, NJ) coupled to goat F(ab')2 anti-mouse IgG (Pierce Chemical Co., Rockford, IL), as previously described (3). Immunoadsorbed proteins, eluted by boiling in Laemmli sample buffer containing 5% 2-mercaptoethanol, were separated by SDS-PAGE in parallel with Rainbow protein molecular weight markers (Amersham Corp., Arlington Heights, IL) and transferred to nitrocellulose membranes. After blocking, the blots were incubated sequentially with 1/1,000 dilution of anti-y-chain rabbit serum and horseradish peroxidase-linked protein G (Bio Rad Laboratories, Hercules, CA) followed by enhanced chemiluminescence detection (ECL; Amersham). 
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Results
The AflJnity for Ligand of Both the Human and the Murine Fc~/RI Increased when the Receptors were Cotransfected with the T-Chain Subunit in COS Cells.
Both the human and the murine FcyRI cDNAs were transfected into COS cells either alone or with ",/chain, and the affinity of Fc',/RI for IgG was measured in ligand-binding assays using 12SI-labeled IgG2a, a murine IgG isotype that both species of FcyRI bind with high affinity (11) . The saturation binding data, corrected for nonspecific binding and analyzed by the Scatchard method, produced a straight line for both the human FcyRI and routine Fc'yRI COS cells transfected with and without y chain, which is indicative of a single population of receptors with a single affinity for IgG (Fig. 1) . The equilibrium association constants (K~) of the Fc~/RI transfectants were determined from the slope of the line obtained in the Scatchard plots ( Table 1) . The human and the murine FcyRI transfected into COS cells bound monomeric IgG2a with a K a of 3.2 + 0.3 • 107 M -1 and a K~, of 4.9 + 0.4 X 107 M -1, respectively (Table 1) , similar to affinities previously reported for these transfectants (8, 14) . The affinity for the ligand of Fc~/RI expressed in another fibroblast cell line, a murine 3T3 cell line stably transfected with a human FcyRI cDNA, was found to be nearly identical, with a K a of 3.5 • 107 M -~.
When the human y chain was cotransfected with hulnan Fc'yRI in COS cells, the binding affinity of the receptor for monomeric IgG2a was increased fivefold to a K~ of 15.6 X 107 M -1 ( Fig. 1 and Table 1 ). The binding affinity of FcyRI expressed on IFN-',/-treated U937 cells, a human monocytic cell line that naturally expresses both FcyRI and ",/ chain, was also measured and an average K, of 19.0 • 107 M 1 was found, which was in agreement with previous reports (11) and very similar to the binding affinity measured on the COS cells cotransfected with the human Fc~/RI and -/chain. Similar results were obtained with the murine Fc',/RI cotransfected with ",/chain in COS cells. Cotransfection of the murine ~/chain induced a twofold increase in the affinity of the receptor for mlgG2a, with a K~ of 9.1 + 0.3 • 107 M -1, an affinity that is comparable to the one reported on the murine macrophage cell line P388DI, which had a K a of 11.0 • 107 M -1 (12) . The difference in binding affinities for both the human and the murine Fc~RI that was measured when the receptor was transfected alone or with y chain in COS cells was demonstrated to be statistically significant when analyzed by Student's two-tailed t test.
The human and the murine ~/ chains, which share 86% amino acid identity (15) , substituted equally for each other in increasing the binding affinity of Fc~/RI. The human Fc~/RI cotransfected with the murine ~/chain showed a K~ of 14.5 • 107 M -1, which is almost identical to the affinity that was measured when cotransfected with the human y chain. The binding affinity of the murine FcyRI, when cotransfected with the human ",/chain, was also nearly identical to what was measured when the receptor was cotransfected with the murine y chain, a K~ of 9.2 • 107 M -1.
To exclude the possibility that the increase in binding affinity of Fc~/RI for ligand was a nonspecific effect of cotransfection, both the human and the murine FcyRI were cotransfected in COS cells with several control cDNAs, including the human macrophage mannose receptor cDNA and several expression vectors, pHMR, pRSVCAT, and pcDNAI. The binding of these FcyRI transfectants was analyzed as before, and the resulting K, determined by the Scatchard method were 3.2 + 0.3 • 107 M -t and 4.1 + 0.7 • 107 M -1 for human and murine Fc~/RI, respectively, when cotransfected with nonspecific cDNA (Table 1) . Thus, cotransfection of nonspecific cDNA did not change the affinities of human and murine Fc~/RI.
Cotransfection of the 7t chain with human Fc~/RI also appeared to affect the number of expressed receptors. Although the expression levels in transient transfectants can be variable, the consistency with which y chain decreased the Bin, ~ of the human F c y R I suggested that the change in the concentration of receptor sites may be specific to y-chain cotransfection. Unlike the human receptor, h o wever, the Bm~ x measured for the murine F c y R I cotransfected with "y chain was not different from the Bm~ x obtained with F c y R I alone.
The Changes in Binding Affinity for IgG Correlate with the Association o f t Chain with FcTRI. W e have previously shown
that the association of the human F c y R I with human y chain can be reconstituted in C O S ceils (3). To confirm that this association was present in our experimental conditions and to determine if the murine F c y R I association with the murine y chain was also reconstituted in C O S cell transfections, we analyzed transfectants by Western blot after immunoadsorption with antibodies against human F c y R I (197) or y chain (4D8) (Fig. 2) . Since antibody 197 is an IgG2a isotype, it was also used as a ligand to adsorb the murine F c y R I because of the lack of specific antibodies for this receptor. The anti-y-chain immunoblot antibody recognized a 10-kD protein copurifying with FcyRI in imnmnoadsorbates from cells transfected with human F c y R I and human y chain (Fig. 2 A, lane 2) , and from cells transfected with nmrine F c y R I and human y chain (Fig. 2 A,  lane 4) . A band that was the appropriate size for y chain was also copurified from cells in which the human F c y R I was cotransfected with the murine y chain (Fig. 2 B, lane  4) , as well as from cells cotransfected with the murine F c y R I and the murine y chain (Fig. 2 B, lane 5) . Direct immunoadsorption o f y chain with anti-y-chain n~Ab 4D8 confirmed the presence of y chain in the appropriate ceils (Fig. 2 A, lanes 2 and 4, and B, lanes, 4 and 5) .
The Association of FcTRI with Y Chain and the Subsequent Increase in Binding Affinity are Independent of the Cytoplasmic Domain of the Receptor. To investigate if the transmem-
brane domain of F c y R I was sufficient for association with y chain as well as for the increase in binding affinity mediated by y chain, a truncated form of the human F c y R I containing the extracellular and transmernbrane domains o f the receptor without the cytoplasmic domain (FF) was constructed and transfected into C O S ceils with or without y chain. Western blot analysis with an anti-y-chain antibody showed a 10-kD band (Fig. 2 A, lane 7) in cells that had been cotransfected with the truncated construct and y chain, and immunoadsorbed with either anti-FcyRI or anti-y-chain antibodies, indicating that y chain was expressed in these cells and was coimmunoadsorbed with the truncated F c y R I mutant.
The increase in binding affinity o f F c y R I induced by y chain was not affected by the absence of the cytoplasmic Table 1 ), indicating that the cytoplasmic domain of F c y R I is not required for enhanced binding affinity. The binding affinity of the truncated F c y R I transfected without y chain was twofold higher than that of the wild-type receptor (P = 0.025); however, no significant difference was seen in the affinity of the two receptors that were cotransfected with y chain (P = 0.400).
Association with y Chain Confers Medium Affinity Binding to
FcyRIII. To determine if the medium affinity of FcyRIIIa for monomeric IgG is caused by its association with "/ chain, COS ceils were transfected with either the FcyRIIIa isoform, which requires cotransfection and association with "y chain for ceil-surface expression, or the Fc~RIIIb isoform, a GPI-linked form of the receptor that does not associate with "y chain. We also transfected an FcyRIIIa mutant, resulting in a GPI-linked form of the receptor whose expression was independent of ~/-chain association. The three Fc~RIII constructs transfected in COS cells were analyzed simultaneously for ligand affinity by IgG-binding assay and for expression by flow cytometry. Table 2 shows the results of representative Scatchard and flow cytometric analyses of the same set of transfected COS ceils, comparing ligand binding affinity and surface expression of the three Fc~/RIII. The affinity of FcyRIIIa cotransfected with y chain (1.2 X 107 M -l) demonstrated an ~10-fold increase when compared to the affinity measured for the FcyRIlla GPI mutant (0.1 • 107 M-l), while the affinity of Fc~RIIIb could not be calculated because of the low level ofligand binding. The expression of the three Fc~/RIIIs was analyzed with an anti-FcyRIII antibody by flow cytometry to insure that the lower binding and affinities that were measured for FcyRllIb and FcyRIIIa GPI were not caused by low levels of expression ( Table 2 ). The three Fc',/R were expressed in COS ceils, with Fc',/RIIIa/~/ chain expressing less than the Fc3~RIIIb or Fc',/RIIIa-GPI mutant, confirming an absence of correlation between binding affinity and levels of receptor expression. Similar results were obtained in two additional ligand-binding assays and flow cytometric analyses.
Discussion
The functions that the 3, chain provides in its association with FcyR continue to be defined. We have now shown that y chain, in addition to its roles in receptor expression Equilibrium association constants of one representative ligand-binding assay ofmonomeric I25I-tgG2a to COS-7 cells transfected with FcyRIlla and the ~/ chain, Fc',/RIIlb, and an Fc~/RIIIa GPI mutant, each point done in triplicate as described in Fig. 1 and signal transduction, modifies the affinity of FqR for ligand. In this study, we demonstrated that the high affinity for monomeric IgG that characterizes both the human and murine FcyRI was dependent upon ",/-chain cotransfection with the receptor, thus explaining the discrepancy between the lower binding affinity reported for FcyRI transfected into COS ceils and the higher affinity measured on ceils that naturally express the receptor. Association of'y chain increased the binding affinity of human FqRI fivefold, and the affinity of the murine receptor twofold. While the level of affinity increase was lower in the mouse, the y chain brought the affinity of both species of FcyRI to the levels reported on ceils that naturally express the receptors. The differences observed between the human and the murine FcyRI when cotransfected with 21 chain in COS cells did not appear to be related to the species of y chain that was cotransfected with the receptors, since similar results were obtained when each receptor was cotransfected with the y chain from the other species, suggesting differences within the structure of the receptors themselves. In fact, the reported range of binding affinity for the human FcyRI, Ka of 108-9 M -1 (10), is slightly higher than the affinity reported on murine macrophages,/Ca of 1.1 • 108 M -1 (12) , an observation our data supports. Our findings also suggest that the Fc~/RIIIa isoform, the "medium affinity" Fc~/R, has a higher affinity for monomeric IgG than the Fc-/RIIIb isoform because of its association with "y chain. The affinity of an Fc',/RIIIa GPI mutant, expressed without the requirement of the y chain, was 10-fold less than the affinity measured for FcyRIIIa cotransfected with the y chain. We had previously postulated that y chain associated with Fc',/RI through the transrnembrane domain of the receptor due to homology of this region to the transmembrane domains of FceRl and Fc',/RItla (3), both shown to associate with y chain through their transmembrane domains (16) . With only five putative extracellular amino acids (15) , it is unlikely that ~/chain associated with Fc',/RI or induced its change in affinity through an interaction at the extracellular level. Analysis of a truncated Fc~/RI lacking its cytoplasmic domain not only supported the hypothesis that ~/ chain associated with the transmembrane domain of the receptor, but also demonstrated that the cytoplasmic domain of the receptor was not required for the increased binding affinity conferred by association with ",/ chain. In fact, we observed a slight but significant increase in the affinity of the truncated Fc',/RI when compared to the wildtype Fc',/RI, which suggests that the cytoplasmic domain may actually have an inhibitory effect upon binding affinity. When the receptors were cotransfected with y chain, however, there was no longer a significant difference in the binding affinity of the truncated Fc2cRI compared to the wild-type receptor, suggesting "/-chain association may overcome any inhibitory effect of the Fc',/RI cytoplasmic domain to confer the appropriate receptor structure for high affinity binding.
It has been inferred previously that the unique third extracellular domain of Fc~/RI is responsible for its high affinity binding of monomeric IgG (8, 14) . In one study, a murine Fc`/R chimera lacking the third extracellular domain and containing only the first two extracellular domains of Fc',/RI spliced to the transmembrane and cytoplasmic domain of Fc`/RII bound IgG with the same low affinity and binding specificity as Fc~/RII (13). While we have shown that `/ chain association is required for maximum binding affinity, Fc`/RI expressed without the ",/ chain still bound IgG with an affinity higher than the other Fc~/R, indicating that the high affinity binding of this receptor may be a result of contributions from the extracellular domain along with the association to the -/-chain subunit. The role of the extracellular domain was also apparent in our Fc`/RIII experiments. Both of the two GPI-linked forms ofFcyRIII, a and b, bound ligand with low affinity; however, the affinity of Fc~/RIIIa could be measured, while the binding of FcyRIIIb was too low for an accurate affinity to be determined, even though the two receptors were expressed at similar levels. These findings suggest that the six-amino acid differences between the extracellular domain of Fc~/RIIIa and Fc'yRIIIb (17) , in addition to association with `/chain, contributed to the higher binding affinity of this receptor. For both Fc~/RI and FcyRIII, it appeared that the structure of the extracellular domains affects binding affinity, and that association with -/ chain further increases the affinity for ligand, probably through a change of the quaternary structure of the receptors.
While increased binding affinity due to an associated subunit is a novel observation among FcyR, a similar phenomenon has been described for members of the cytokine receptor family. Like Fc~/R, hematopoietic cytokine receptors are characterized by pleiotropy and redundancy, and lacking a tyrosine signaling motif in their cytoplasmic domain, they associate with common subunits including gp130, KH97, and the IL receptor "y chain (18) (19) (20) (21) (22) , which are responsible for mediating the receptor signal. Like Fc~/RI, these cytokine receptors when expressed alone bind ligand with relatively low affinity but are transformed to high affinity receptor complexes upon association with their subunits. An explanation has been proposed for the affinity increase of these receptors upon association with the signaling subunit: receptors that do not have built-in signaling motifs and instead rely upon associated subunits might require a higher binding affinity for ligand to give the receptor the time that is necessary to transmit signals through the associated subunit (18) . This hypothesis may also be relevant to Fc~/R, since Fc~/RII, which contains a signaling motif within its cytoplasmic domain, binds monomeric IgG with lower affinity than Fc`/RI and Fc~/RIIIa, both of which rely on association with the `/ chain to transmit signals to the cell. It would appear that the ability of the ~/chain to modify the affinity of Fc2cR for ligand is not only a novel observation among FcR, but it may also have a wider significance, suggesting that in addition to their roles in signal transduction, associated subunits may regulate receptorligand interaction.
